Literature DB >> 23455188

The significance of immunohistochemical expression of merlin, Ki-67, and p53 in meningiomas.

Sanda Pavelin1, Kristijan Bečić, Gea Forempoher, Snježana Tomić, Vesna Capkun, Irena Drmić-Hofman, Ivana Mrklić, Ivo Lušić, Zenon Pogorelić.   

Abstract

Meningiomas are one of the most common CNS tumors whose appearance is closely linked to NF2 gene product merlin. Tumor markers Ki-67 and p53 play established role in tumor progression which should be analyzed in close association with merlin expression. The aim of this study was to investigate the immunohistochemical expression of merlin in meningiomas, correlation with Ki-67 and p53, and to determine the association of these results with histologic grade and subtype. The histologic sections of 170 patients with totally resected meningiomas, between January 2000 and December 2010, were classified according to WHO, immunohistochemically stained for Ki-67, p53, and merlin, and analyzed using light microscope. Ki-67 median was 5.6 times higher in group of patients with negative merlin than in those with positive merlin (P=0.05). Statistically significant correlation of merlin with p53 was found (P<0.001). Merlin expression between 2 combined groups (meningothelial/secretory and fibroblastic/transitional) was statistically significant (P=0.002). By comparing merlin expression and p53 levels, statistically significant difference was found (P=0.017). In the group with positive merlin and negative p53 as well as positive merlin and low p53, meningothelial/secretory subtypes of meningiomas were more common. In combination of negative merlin and negative p53 as well as negative merlin and high p53, there were more meningiomas of fibroblastic/transitional subtype. There was no statistically significant correlation between merlin and tumor grade (P=0.420). There is undeniable influence of merlin on the development and the proliferative ability of meningioma subtypes. Significant role of p53 pathway was confirmed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23455188     DOI: 10.1097/PAI.0b013e318289f490

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  9 in total

1.  Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.

Authors:  Sayaka Yuzawa; Hiroshi Nishihara; Shigeru Yamaguchi; Hiromi Mohri; Lei Wang; Taichi Kimura; Masumi Tsuda; Mishie Tanino; Hiroyuki Kobayashi; Shunsuke Terasaka; Kiyohiro Houkin; Norihiro Sato; Shinya Tanaka
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

2.  Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.

Authors:  Yuhao Shi; Saumya R Bollam; Shannon M White; Sean Z Laughlin; Garrett T Graham; Mandheer Wadhwa; Hengye Chen; Chan Nguyen; Jeremie Vitte; Marco Giovannini; Jeffery Toretsky; Chunling Yi
Journal:  Dev Cell       Date:  2016-11-03       Impact factor: 12.270

3.  Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma.

Authors:  David B Chapel; Jason L Hornick; Julianne Barlow; Raphael Bueno; Lynette M Sholl
Journal:  Mod Pathol       Date:  2022-04-22       Impact factor: 8.209

4.  Abundant immunohistochemical expression of dopamine D2 receptor and p53 protein in meningiomas: follow-up, relation to gender, age, tumor grade, and recurrence.

Authors:  G Trott; J F S Pereira-Lima; C G S Leães; N P Ferreira; L M Barbosa-Coutinho; M C Oliveira
Journal:  Braz J Med Biol Res       Date:  2015-03-03       Impact factor: 2.590

5.  Molecular Targets and Treatment of Meningioma.

Authors:  Rickey Miller; Michele L DeCandio; Yaenette Dixon-Mah; Pierre Giglio; W Alex Vandergrift; Naren L Banik; Sunil J Patel; Abhay K Varma; Arabinda Das
Journal:  J Neurol Neurosurg       Date:  2014

6.  Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.

Authors:  B R Ongaratti; C B O Silva; G Trott; T Haag; C G S Leães; N P Ferreira; M C Oliveira; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

Review 7.  Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Mirna Lechpammer
Journal:  Cancers (Basel)       Date:  2016-07-15       Impact factor: 6.639

8.  Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas.

Authors:  Yujie Deng; Xiaohui Chen; Yuhong Ye; Xi Shi; Kunshou Zhu; Liming Huang; Sheng Zhang; Mingang Ying; Xuede Lin
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05

9.  RNA-seq transcriptome analysis of formalin fixed, paraffin-embedded canine meningioma.

Authors:  Jennifer K Grenier; Polly A Foureman; Erica A Sloma; Andrew D Miller
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.